FIELD: medicine, pharmacology. SUBSTANCE: the innovation refers to developing hemostimulants to treat hypoplastic states in blood system under conditions of chemotherapy and at the action of extreme factors (ionizing radiation, different venoms, toxins, etc.). The given preparation contains defibrinated blood of Siberian stag or dappled deer dried to achieve 4-5% moisture in a vacuum reservoir with heated up walls at 45 C, not more, and vacuum range being 5-600 mm mercury column. EFFECT: increased pharmacological activity at low toxicity level. 2 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| HEMOSTIMULATING AGENT | 1994 |
|
RU2088249C1 |
| MEDICINAL AGENT STIMULATING ERYTHROID AND GRANULOCYTE ERYTHROPOIESIS STEMS AT CYTOSTATIC MYELODEPRESSIONS | 1993 |
|
RU2083201C1 |
| MEDICINE CAPABLE OF SELECTIVELY STIMULATING GRANULO-MONOCYTOPOIESIS IN CASE OF HYPOPLASIA OF MEDULLARY HEMOPOIESIS TRIGGERED BY CYTOSTATIC | 1988 |
|
RU2020936C1 |
| MEDICINAL AGENT STIMULATING ERYTHROIDE HEMOPOIESIS GERM AT CYTOSTATIC MYELODEPRESSION STATES | 1992 |
|
RU2061475C1 |
| METHOD OF MYELOPOIESIS STIMULATION | 2008 |
|
RU2366452C1 |
| HEME STIMULATING AGENT | 1994 |
|
RU2094045C1 |
| PSYCHOACTIVATOR "PANTOHEMATOGEN" | 1992 |
|
RU2008008C1 |
| METHOD OF GRANULOCYTOPENIA-STIMULATING EFFECT EVALUATION FOR PHARMACOLOGICAL SUBSTANCES | 2006 |
|
RU2332667C1 |
| METHOD OF MYELOPOIESIS STIMULATION | 2007 |
|
RU2336899C1 |
| AGENT ELICITING ANTIHYPERLIPOPROTEINEMIC ACTIVITY, FOOD SUPPLEMENT BASED ON THEREOF AND METHOD OF TREATMENT OF LIPID METABOLISM DISTURBANCE IN PATIENTS WITH CARDIOVASCULAR DISEASES | 2001 |
|
RU2201239C1 |
